We know that you are all aware of the significant global challenges presented by the coronavirus COVID-19 outbreak. FIP has a duty of care to its members, volunteers and congress participants. Consequently, we are in close contact with the World Health Organization (WHO), globally and regionally. Our policy is to follow WHO health advisories, together with specific guidance issued by national, provincial and state governmental offices. We are also in regular contact with our partner organisations collaborating on planned events such as the 7th Pharmaceutical Sciences World Congress (PSWC) that is scheduled from 22 to 27 May 2020 in Montreal, Canada.
The well-being of our congress participants is our priority. At present, we are evaluating the logistics for and advisability of holding this important event for pharmaceutical scientists on the intended dates, still with the objective to deliver a high-level programme. We are cognisant that travel advisories implemented by a number of countries and/or private organisations may severely limit attendance of speakers and delegates at the PSWC. An official decision regarding the PSWC in May is anticipated next week and further details will be communicated to all relevant parties accordingly. We ask that, while we are taking this decision, you put your preparations for attending PSWC 2020 on hold.
We thank you for your understanding and solidarity during these uncertain times.
With best wishes,
Mr Dominique Jordan
President
Dr Catherine Duggan
Chief Executive Officer
Prof Denis deBlois
Chair, PSWC 2020
Prof Giovanni Pauletti
Scientific Secretary